ATE411004T1 - Wirkstofffreigabesystem für photosensibilisatoren - Google Patents

Wirkstofffreigabesystem für photosensibilisatoren

Info

Publication number
ATE411004T1
ATE411004T1 AT02721896T AT02721896T ATE411004T1 AT E411004 T1 ATE411004 T1 AT E411004T1 AT 02721896 T AT02721896 T AT 02721896T AT 02721896 T AT02721896 T AT 02721896T AT E411004 T1 ATE411004 T1 AT E411004T1
Authority
AT
Austria
Prior art keywords
production
photosensitizers
drug release
release system
methods
Prior art date
Application number
AT02721896T
Other languages
English (en)
Inventor
Ronald Boch
Dev Singh
Iman Karmadi
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Application granted granted Critical
Publication of ATE411004T1 publication Critical patent/ATE411004T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT02721896T 2001-04-11 2002-04-10 Wirkstofffreigabesystem für photosensibilisatoren ATE411004T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/833,406 US6984395B2 (en) 2001-04-11 2001-04-11 Drug delivery system for hydrophobic drugs

Publications (1)

Publication Number Publication Date
ATE411004T1 true ATE411004T1 (de) 2008-10-15

Family

ID=25264324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02721896T ATE411004T1 (de) 2001-04-11 2002-04-10 Wirkstofffreigabesystem für photosensibilisatoren

Country Status (11)

Country Link
US (3) US6984395B2 (de)
EP (2) EP1900357A3 (de)
JP (3) JP4194847B2 (de)
AT (1) ATE411004T1 (de)
CA (1) CA2439500C (de)
DE (1) DE60229366D1 (de)
ES (1) ES2315359T3 (de)
NZ (1) NZ527922A (de)
RU (1) RU2279872C2 (de)
WO (1) WO2002083097A2 (de)
ZA (1) ZA200306728B (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
AU2002336867A1 (en) * 2001-11-02 2003-05-12 Qlt Inc. Micelle compositions containing pegylated phospholipids and a photosensitizer
TW200307563A (en) * 2002-02-14 2003-12-16 Sixty Inc C Use of BUCKYSOME or carbon nanotube for drug delivery
CA2490959C (en) 2002-07-02 2013-04-16 Board Of Regents, The University Of Texas System Radiolabeled compounds and liposomes and their methods of making and using the same
AU2003296335A1 (en) * 2002-12-06 2004-06-30 Board Of Regents, The University Of Texas System Compositions and methods related to lipid:emodin formulations
WO2004096113A2 (en) 2003-04-28 2004-11-11 Medical Instill Technologies, Inc. Container with valve assembly for filling and dispensing substances, and apparatus and method for filling
US11324698B2 (en) 2003-08-28 2022-05-10 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
US20070003607A1 (en) * 2003-09-02 2007-01-04 Vibhudutta Awasthi Neutral liposome-encapsulated compounds and methods of making and using thereof
WO2005070465A2 (en) * 2004-01-14 2005-08-04 Gilead Sciences, Inc. Lipid-based dispersions useful for drug delivery
CA2457214A1 (en) * 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
NZ551636A (en) * 2004-06-09 2009-12-24 Quadra Logic Tech Inc Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins
CN1840193B (zh) * 2005-03-29 2010-05-12 中国科学院生物物理研究所 聚乙二醇化磷脂包载的蒽环类抗肿瘤抗生素的纳米胶束制剂
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
ES2275443B1 (es) * 2005-11-30 2008-06-01 Italfarmaco, S.A. Procedimiento de preparacion de liposomas.
US20070154403A1 (en) * 2006-01-05 2007-07-05 Thomas Skold Oral, Pulmonary and Transmucosal Delivery Composition
US9222728B2 (en) * 2006-04-24 2015-12-29 Medinstill Development Llc Penetrable and resealable lyophilization device
CA2650825C (en) * 2006-05-02 2015-07-14 University Of Miami Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds
US8858989B2 (en) * 2006-05-18 2014-10-14 Biolitec Pharma Marketing Ltd Gel-formulations of hydrophobic photosensitizers for mucosal applications
US8211051B2 (en) * 2006-09-24 2012-07-03 Delaporte Stephen E Electroactive polymer actuated cerebrospinal fluid shunt
CZ298978B6 (cs) * 2006-11-28 2008-03-26 Fyziologický ústav AV CR Liposomální gelový ftalocyaninový prípravek pro fotodynamickou terapii nádorových onemocnení a zpusob jeho prípravy
JP5515075B2 (ja) * 2007-01-18 2014-06-11 国立大学法人 千葉大学 微粒子製剤
EP2200613B1 (de) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazin-derivate und ihre verwendungen
RU2367434C1 (ru) * 2008-04-22 2009-09-20 Виктор Александрович Борисов Фотосенсибилизатор и способ его получения
NZ593735A (en) * 2008-12-26 2013-08-30 Samyang Biopharmaceuticals Preparation method of polymeric micellar nanoparticles composition containing a poorly water-soluble drug
US8709473B1 (en) * 2009-01-28 2014-04-29 Abbott Cardiovascular Systems Inc. Method of targeting hydrophobic drugs to vascular lesions
US20100233224A1 (en) * 2009-02-23 2010-09-16 Epir Technologies, Inc. Photolytic release of biocides for high efficiency decontamination through phospholipid nanoparticles
US8815931B2 (en) * 2009-04-28 2014-08-26 Biolitec Pharma Marketing Ltd Oral formulations for tetrapyrrole derivatives
US9000246B2 (en) 2009-10-12 2015-04-07 Elevance Renewable Sciences, Inc. Methods of refining and producing dibasic esters and acids from natural oil feedstocks
KR20120086729A (ko) * 2009-11-20 2012-08-03 클라비스 파마 에이에스에이 젬시타빈 유도체의 비경구적 제제
US8974818B2 (en) * 2010-01-20 2015-03-10 Henry Wu Custom-formulated phospholipid microbubbles and methods and uses thereof
JP2012184199A (ja) * 2011-03-07 2012-09-27 Nara Institute Of Science & Technology フラーレン誘導体を用いた水溶性光増感性材料
CN102302450B (zh) * 2011-09-06 2013-02-27 复旦大学 疏水药物-白蛋白-葡聚糖纳米乳液及其制备方法和应用
KR102284689B1 (ko) * 2011-10-21 2021-08-02 셀라토 파마슈티칼즈, 인코포레이티드 동결건조된 리포좀
CA2876139A1 (en) * 2012-06-07 2013-12-12 President And Fellows Of Harvard College Nanotherapeutics for drug targeting
JP6112498B2 (ja) * 2012-07-20 2017-04-12 株式会社 Ｍ Ｌａｂｓ 防腐剤・界面活性剤フリーの化粧品原料液、化粧品及び化粧品原料液の調製法
ES2764090T3 (es) 2012-12-19 2020-06-02 Univ New York State Res Found Composiciones y procedimiento para la liberación activada por la luz de materiales de nanovesículas
FI3922241T3 (fi) 2013-02-01 2023-11-28 Celator Pharmaceuticals Inc Niukasti liukoisten lääkkeiden etälataus liposomeihin
GB201318787D0 (en) * 2013-10-24 2013-12-11 Univ Leiden Upconverting vehicles and uses
EP3177269A4 (de) 2014-08-04 2018-02-28 Zoneone Pharma, Inc. Fernladung von schwach wasserlöslichen medikamenten in lipidvesikel
JP6036879B2 (ja) * 2015-03-04 2016-11-30 栗田工業株式会社 水処理用選択性透過膜及びその製造方法
CN107613962B (zh) * 2015-04-02 2021-02-09 纽约州立大学研究基金会 血清稳定组合物和用于光触发的材料释放的方法
WO2017048860A1 (en) 2015-09-14 2017-03-23 Vgsk Technologies, Inc. A sterically stabilized carrier for subcutaneous, sublingual and oral therapeutics, compositions and methods for treating a mammal
DK3634391T3 (da) 2017-05-17 2025-03-31 Bpgbio Inc Anvendelse af coenzym q10-formuleringer i behandlingen og forebyggelsen af epidermolysis bullosa
RU2674025C1 (ru) * 2017-10-25 2018-12-04 Общество с ограниченной ответственностью "Научно-производственная фирма "ЭЛЕСТ" (ООО "НПФ "ЭЛЕСТ") Лекарственное средство на основе порфиринового фотосенсибилизатора копропорфирина для лечения рака кожи методом фотодинамической терапии
WO2019173884A1 (pt) * 2018-03-15 2019-09-19 Bebeachibuli Romeo Normalizador biológico, processo de obtenção de normalizador biológico e produtos obtidos com o normalizador biológico
US10716758B2 (en) * 2018-04-09 2020-07-21 Southwest Research Institute Liposomal statin formulation
EA038105B1 (ru) * 2018-06-13 2021-07-07 Тютор С.А.С.И.Ф.И.А. Способ получения фармацевтической композиции, содержащей бортезомиб, продукт способа
CN111569074B (zh) * 2020-06-18 2021-05-04 吉林大学 一种兼具选择性及光热抗菌性能的纳米片层、制备方法及其应用
WO2022235907A1 (en) 2021-05-05 2022-11-10 Vgsk Technologies, Inc. Liposome-encapsulated corticosteriods inhibit sars-cov-2 replication and reduces lung inflammation
CN119326732B (zh) * 2024-10-25 2025-08-05 福建医科大学附属协和医院 响应并调控动脉血栓微环境的三元纳米自组装颗粒及其制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5435989A (en) * 1982-03-30 1995-07-25 Vestar, Inc. Method of targeting a specific location in a body
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4512762A (en) * 1982-11-23 1985-04-23 The Beth Israel Hospital Association Method of treatment of atherosclerosis and a balloon catheter for same
US4577636A (en) * 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
US4753788A (en) * 1985-01-31 1988-06-28 Vestar Research Inc. Method for preparing small vesicles using microemulsification
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
JPS63130537A (ja) * 1986-11-19 1988-06-02 Ichimaru Pharcos Co Ltd プラセンタ−由来生理活性物質含有皮膚用剤
US5320906A (en) * 1986-12-15 1994-06-14 Vestar, Inc. Delivery vehicles with amphiphile-associated active ingredient
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4946683A (en) * 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
US5096629A (en) * 1988-08-29 1992-03-17 501 Nippon Fine Chemical Co., Ltd. Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
US5010073A (en) * 1989-10-05 1991-04-23 The Rockefeller University Use of liposomes as carriers for metalloporphyrins
US5270053A (en) * 1990-04-03 1993-12-14 Ciba-Geigy Corp. Parenterally administerable liposome formulation comprising synthetic lipid
CA2047969A1 (en) * 1990-08-17 1992-02-18 Thomas D. Madden Benzoporphyrin vesicles
US5095629A (en) * 1991-01-31 1992-03-17 Spectra-Physics Laserplane, Inc. Laser beam target
US5312617A (en) * 1991-05-23 1994-05-17 Unger Evan C Liposoluble compounds useful as magnetic resonance imaging agents
CA2087902C (en) * 1992-02-05 2006-10-17 Narendra Raghunathji Desai Liposome compositions of porphyrin photosensitizers
WO1994022468A1 (en) * 1993-04-02 1994-10-13 Anticancer, Inc. Method for delivering beneficial compositions to hair follicles
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US5257970A (en) * 1992-04-09 1993-11-02 Health Research, Inc. In situ photodynamic therapy
US5329029A (en) * 1992-11-05 1994-07-12 Wan Barbara Y Phosphatidylalkanolamine derivatives and their use in generating phospholipid conjugates
ATE192331T1 (de) * 1993-02-26 2000-05-15 Fountain Pharm Inc Abgabesystem für impfstoffe und lagerstabile vorstufenlösung zur nachträglichen verkapselung von aktivstoffen
FR2715566B1 (fr) * 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.
FR2715846A1 (fr) * 1994-02-07 1995-08-11 Rhone Poulenc Rorer Sa Nouvelle composition pharmceutique à base de taxoïdes.
US5833948A (en) * 1995-06-15 1998-11-10 Bracco Research S.A. Blood-pool imaging composition comprising micelles containing a lipophilic chelating agent and a non-ionic surfactant
US5707608A (en) 1995-08-02 1998-01-13 Qlt Phototherapeutics, Inc. Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizer
US5885557A (en) * 1996-02-08 1999-03-23 Estee Lauder Inc. Compositions useful in the phototherapeutic treatment of proliferative skin disorders
US6375930B2 (en) * 1996-06-04 2002-04-23 Board Of Regents, The University Of Texas System Membrane incorporation of texaphyrins
IL128632A (en) * 1996-08-22 2003-03-12 Rtp Pharma Corp Compositions comprising microparticles of water-insoluble substances and method for preparing same
US6010890A (en) 1997-04-29 2000-01-04 New York Blood Center, Inc. Method for viral inactivation and compositions for use in same
US5880145A (en) * 1997-05-07 1999-03-09 The University Of British Columbia Class of benzoporphyrin derivative photoactive compounds
NZ338031A (en) * 1997-05-07 2001-04-27 Qlt Phototherapeutics Inc Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents and their use in conducting photodynamic diagnosis
DK0983272T3 (da) * 1997-05-07 2004-03-01 Univ British Columbia En ny klasse af fotoaktive forbindelser, der består af benzoporphyrinderivater
DE19838636A1 (de) * 1998-08-26 2000-03-02 Basf Ag Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein
US6331235B1 (en) 1998-12-11 2001-12-18 The University Of British Columbia Chiral separation of benzoporphyrin derivative mono-and di-acids by laser-induced fluorescence capillary electrophoresis
CA2408332C (en) 2000-05-08 2011-02-15 The University Of British Columbia Supports for photosensitizer formulations
US6696081B2 (en) * 2000-06-09 2004-02-24 Duke University Carbohydrate based lipid compositions and supramolecular structures comprising same
KR100392501B1 (ko) * 2000-06-28 2003-07-22 동국제약 주식회사 다중 에멀젼법에 의한 서방출성 미립구의 제조방법
US6984395B2 (en) 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
WO2003026588A2 (en) 2001-09-28 2003-04-03 Esperion Therapeutics, Inc. Methods and apparatus for extrusion of vesicles at high pressure

Also Published As

Publication number Publication date
EP1900357A2 (de) 2008-03-19
HK1060285A1 (en) 2004-08-06
WO2002083097A3 (en) 2003-03-13
JP4194847B2 (ja) 2008-12-10
RU2279872C2 (ru) 2006-07-20
WO2002083097A2 (en) 2002-10-24
EP1377274A2 (de) 2004-01-07
EP1377274B1 (de) 2008-10-15
US20100247447A1 (en) 2010-09-30
CA2439500C (en) 2008-11-18
JP2004532219A (ja) 2004-10-21
US20060039965A1 (en) 2006-02-23
ES2315359T3 (es) 2009-04-01
US8852629B2 (en) 2014-10-07
JP2012224634A (ja) 2012-11-15
JP5154296B2 (ja) 2013-02-27
ZA200306728B (en) 2004-09-17
EP1900357A3 (de) 2009-05-20
NZ527922A (en) 2005-09-30
DE60229366D1 (de) 2008-11-27
JP2008201807A (ja) 2008-09-04
CA2439500A1 (en) 2002-10-24
US6984395B2 (en) 2006-01-10
US20020156062A1 (en) 2002-10-24
RU2003132694A (ru) 2005-03-10

Similar Documents

Publication Publication Date Title
ATE411004T1 (de) Wirkstofffreigabesystem für photosensibilisatoren
WO2009064964A3 (en) Switchable nano-vehicle delivery systems, and methods for making and using them
BRPI0406647A (pt) Método para transportar um composto através da barreira sanguìnea do cérebro
WO2005055945A3 (en) Mucoadhesive drug delivery devices and methods of making and using thereof
DE60210552D1 (de) Prozess zur Herstellung einer festen pharmazeutischen Zubereitung welche einen schwerlöslichen Wirkstoff enthält
ATE345775T1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
AU3468900A (en) Cyclodextrin polymers for use as drug carriers
DK1392254T3 (da) Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
ATE329897T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
ATE428401T1 (de) Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten
MD20070267A (en) Gastroresistant pharmaceutical formulation containing rifaximin
DE60126923D1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
MXPA05002814A (es) Formulacion para agentes lipofilicos.
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
NZ527157A (en) Compositions for delivering bisphosphonates
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
CY1112580T1 (el) Συνθεσεις και μεθοδοι για βελτιωμενη απελευθερωση υδροφοβων θεραπευτικων παραγοντων
CY1111022T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
CY1110373T1 (el) Συνεργιστικος συνδυασμος που περιλαμβανει ροφλουμιλαστη και εναν αντιχολινεργικο παραγοντα που επιλεγεται απο αλατα τιοτροπιου για την θεραπεια αναπνευστικων ασθενειων
DE50313292D1 (de) Vernebelbare liposomen und ihre verwendung zur pulmonalen applikation von wirkstoffen
DE60222580D1 (de) Lipidträgerzusammensetzungen und verfahren zur verbesserten wirkstoffzurückhaltung
DE69935526D1 (de) Supramolekulare komplexe enthaltende arzneimittel
GB2446341A (en) Method and system for transdermal drug delivery

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties